VIM and breast cancer: CTC heterogeneity, including differences in gene expression of vimentin and five other EMT markers, was previously highlighted by our group using high-dimensional single-cell transcriptional profiling of human CTCs from breast cancer patients, where cell-to-cell heterogeneity of CTCs was noted even within the same blood draw [101].